<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04439812</url>
  </required_header>
  <id_info>
    <org_study_id>186/20</org_study_id>
    <nct_id>NCT04439812</nct_id>
  </id_info>
  <brief_title>Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer</brief_title>
  <official_title>Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Ramon y Cajal</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Incidence of positive surgical margins after curative gastrectomy ranges from 1% to 20%. It
      has been suggested that positive surgical margins is an adverse prognosis factor, with a
      higher local recurrence and worse overall survival (OS). However, the management of these
      patients remains unclear.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>evaluate the influence of positive margins on the tumour's recurrence and OS after gastrectomy for GC</measure>
    <time_frame>8 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary outcome was to analyse the possible confounding factors that could affect the recurrence and OS after gastrectomy.</measure>
    <time_frame>8 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">267</enrollment>
  <condition>Stomach Neoplasms</condition>
  <arm_group>
    <arm_group_label>R=0</arm_group_label>
    <description>Patients without positive margins after gastrectomy for gastric cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>R=1</arm_group_label>
    <description>Patients with positive margins after gastrectomy for gastric cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>The primary aim of this study was to evaluate the influence of positive margins on the tumour's recurrence and OS after gastrectomy for GC. The secondary outcome was to analyse the possible confounding factors that could affect the recurrence and OS after gastrectomy.</description>
    <arm_group_label>R=0</arm_group_label>
    <arm_group_label>R=1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all consecutive patients who underwent an oncological gastrectomy due to gastric cancer,
        between January 2010 and December 2018 at Ramon y Cajal University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all consecutive patients who underwent an oncological gastrectomy due to gastric
             cancer, between January 2010 and December 2018 at Ramon y Cajal University Hospital.

        Exclusion Criteria:

          -  distant disease (including patients with positive cytology), early postoperative
             mortality (within 30 days after surgery) and follow-up data not available. Resections
             in patients with palliative intent were also excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo Priego, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Ram√≥n y Cajal</affiliation>
  </overall_official>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 17, 2020</study_first_submitted>
  <study_first_submitted_qc>June 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2020</study_first_posted>
  <last_update_submitted>June 17, 2020</last_update_submitted>
  <last_update_submitted_qc>June 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Ramon y Cajal</investigator_affiliation>
    <investigator_full_name>Pablo Priego</investigator_full_name>
    <investigator_title>Consultant surgeon MD, PhD. Associate Profesor of Surgery</investigator_title>
  </responsible_party>
  <keyword>Gastric cancer</keyword>
  <keyword>gastrectomy</keyword>
  <keyword>R1</keyword>
  <keyword>positive margins</keyword>
  <keyword>recurrence</keyword>
  <keyword>overall survival</keyword>
  <keyword>prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

